Novozymes A/S (OTCMKTS:NVZMY) Short Interest Update

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 84,786 shares, an increase of 19,526.4% from the December 15th total of 432 shares. Based on an average daily volume of 118,101 shares, the days-to-cover ratio is currently 0.7 days. Based on an average daily volume of 118,101 shares, the days-to-cover ratio is currently 0.7 days.

Novozymes A/S Stock Down 1.6%

Novozymes A/S stock opened at $64.78 on Tuesday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.00 and a current ratio of 1.61. The firm has a market capitalization of $30.82 billion, a price-to-earnings ratio of 38.33, a price-to-earnings-growth ratio of 1.22 and a beta of 1.09. Novozymes A/S has a fifty-two week low of $53.95 and a fifty-two week high of $75.99. The stock’s fifty day moving average is $62.87 and its two-hundred day moving average is $64.18.

About Novozymes A/S

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

Featured Stories

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.